Little RD, Ward MG, Sparrow MP. Letter to the Editor: can subcutaneous infliximab replace dose-intensified intravenous administration in inflammatory bowel disease? Clin Gastroenterol Hepatol 2022 Sep 22. pii: S1542-3565(22)00913.
PMID: 36155249